Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Non-cash Items (2016 - 2020)

Historic Non-cash Items for InfuSystem Holdings (INFU) over the last 8 years, with Q4 2020 value amounting to $28.4 million.

  • InfuSystem Holdings' Non-cash Items rose 11901.36% to $28.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $28.4 million, marking a year-over-year increase of 11901.36%. This contributed to the annual value of $28.4 million for FY2020, which is 11901.36% up from last year.
  • InfuSystem Holdings' Non-cash Items amounted to $28.4 million in Q4 2020, which was up 11901.36% from $13.0 million recorded in Q4 2019.
  • In the past 5 years, InfuSystem Holdings' Non-cash Items ranged from a high of $28.4 million in Q4 2020 and a low of $616597.0 during Q4 2016
  • Its 5-year average for Non-cash Items is $8.9 million, with a median of $1.7 million in 2018.
  • In the last 5 years, InfuSystem Holdings' Non-cash Items skyrocketed by 5005.9% in 2016 and then skyrocketed by 65540.17% in 2019.
  • Over the past 5 years, InfuSystem Holdings' Non-cash Items (Quarter) stood at $616597.0 in 2016, then skyrocketed by 55.02% to $955868.0 in 2017, then skyrocketed by 79.9% to $1.7 million in 2018, then surged by 655.4% to $13.0 million in 2019, then skyrocketed by 119.01% to $28.4 million in 2020.
  • Its Non-cash Items was $28.4 million in Q4 2020, compared to $13.0 million in Q4 2019 and $1.7 million in Q4 2018.